HealthEquity (NASDAQ:HQY) Shares Gap Down – Time to Sell?

HealthEquity, Inc. (NASDAQ:HQY) gapped down before the market opened on Thursday . The stock had previously closed at $104.42, but opened at $97.16. HealthEquity shares last traded at $89.9870, with a volume of 288,496 shares.

Analyst Ratings Changes

Several equities analysts have recently commented on HQY shares. Weiss Ratings raised HealthEquity from a “hold (c)” rating to a “hold (c+)” rating in a research note on Friday, June 5th. KeyCorp restated an “overweight” rating on shares of HealthEquity in a report on Tuesday, May 26th. Barrington Research reaffirmed an “outperform” rating and issued a $110.00 target price on shares of HealthEquity in a research report on Friday, May 22nd. Royal Bank Of Canada increased their target price on shares of HealthEquity from $100.00 to $108.00 and gave the stock an “outperform” rating in a research note on Wednesday, June 3rd. Finally, Wells Fargo & Company set a $111.00 target price on shares of HealthEquity in a research note on Monday, June 1st. Eleven investment analysts have rated the stock with a Buy rating, one has given a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat.com, HealthEquity presently has an average rating of “Moderate Buy” and an average price target of $110.93.

HealthEquity Stock Down 13.4%

The business has a 50 day simple moving average of $97.77 and a 200 day simple moving average of $87.71. The company has a market capitalization of $7.56 billion, a price-to-earnings ratio of 33.90, a PEG ratio of 1.77 and a beta of 0.21. The company has a debt-to-equity ratio of 0.46, a current ratio of 3.44 and a quick ratio of 3.44.

HealthEquity (NASDAQ:HQY) last issued its quarterly earnings data on Thursday, August 27th. The company reported $1.24 earnings per share for the quarter, beating analysts’ consensus estimates of $1.19 by $0.05. The business had revenue of $350.73 million during the quarter, compared to analysts’ expectations of $349.22 million. HealthEquity had a return on equity of 14.75% and a net margin of 17.25%.The firm’s revenue was up 95.5% compared to the same quarter last year. HealthEquity has set its FY 2027 guidance at 4.660-4.730 EPS. As a group, equities analysts predict that HealthEquity, Inc. will post 3.92 earnings per share for the current fiscal year.

Insider Transactions at HealthEquity

In other news, EVP Michael Henry Fiore sold 2,354 shares of the firm’s stock in a transaction that occurred on Friday, July 10th. The shares were sold at an average price of $95.00, for a total value of $223,630.00. Following the completion of the transaction, the executive vice president owned 52,244 shares of the company’s stock, valued at approximately $4,963,180. This trade represents a 4.31% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold 7,966 shares of company stock worth $756,770 in the last 90 days. 1.60% of the stock is owned by corporate insiders.

Hedge Funds Weigh In On HealthEquity

Several hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Acumen Wealth Advisors LLC acquired a new stake in shares of HealthEquity in the fourth quarter valued at $27,000. Aster Capital Management DIFC Ltd purchased a new position in shares of HealthEquity in the 4th quarter valued at about $28,000. Caitong International Asset Management Co. Ltd boosted its stake in shares of HealthEquity by 1,723.5% in the 4th quarter. Caitong International Asset Management Co. Ltd now owns 310 shares of the company’s stock valued at $28,000 after buying an additional 293 shares during the period. Leonteq Securities AG grew its position in shares of HealthEquity by 159.9% during the first quarter. Leonteq Securities AG now owns 382 shares of the company’s stock worth $32,000 after buying an additional 235 shares in the last quarter. Finally, Silvant Capital Management LLC acquired a new position in shares of HealthEquity during the second quarter worth about $35,000. Hedge funds and other institutional investors own 99.55% of the company’s stock.

About HealthEquity

HealthEquity, Inc (NASDAQ: HQY) is a leading administrator of consumer-directed health accounts and related benefit solutions in the United States. Founded in 2002 and headquartered in Draper, Utah, the company specializes in health savings accounts (HSAs) and offers complementary services such as flexible spending accounts (FSAs), health reimbursement arrangements (HRAs), COBRA administration and commuter benefits. Through its technology-driven platform, HealthEquity enables employers, health plans and individuals to streamline account management, improve cost transparency and encourage more informed healthcare spending.

Serving millions of members across all 50 states, HealthEquity leverages an open-architecture ecosystem that integrates with health plans, payroll providers and financial institutions.